Testing effectiveness (Phase 2)Ended earlyNCT01185366What this trial is testingEverolimus Versus Sunitinib in Non-Clear Cell Renal Cell CarcinomaWho this might be right forKidney Cancer M.D. Anderson Cancer Center 73
Testing effectiveness (Phase 2)UnknownNCT01240005What this trial is testingCytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Qingdao University 30
Not applicableStudy completedNCT00898365What this trial is testingStudy of Kidney Tumors in Younger PatientsWho this might be right forAdult Cystic NephromaAnaplastic Kidney Wilms TumorAngiolipoma+22 more Children's Oncology Group 8,000
Early research (Phase 1)Looking for participantsNCT05856981What this trial is testingPhase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid TumorsWho this might be right forSolid Tumor, AdultMetastatic Solid TumorRefractory Cancer+4 more Sairopa B.V. 130
Not applicableLooking for participantsNCT05023265What this trial is testingAssessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRTWho this might be right forRenal Cell Carcinoma Sunnybrook Health Sciences Centre 70
Not applicableUnknownNCT04244136What this trial is testingResidual Normal Renal Parenchymal and Tumor Volume in Tumor SurgeriesWho this might be right forRenal Cell Carcinoma Assiut University 32
Testing effectiveness (Phase 2)Ended earlyNCT00089102What this trial is testingGemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney CancerWho this might be right forKidney Cancer Medical University of South Carolina 9
Not applicableLooking for participantsNCT06536439What this trial is testingPlanning Operative Strategy Using a Digital Renal Artery Clamping ToolWho this might be right forKidney CancerKidney NeoplasmsKidney Diseases+3 more University Hospital, Ghent 235
Not applicableEnded earlyNCT02005614What this trial is testingA Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose SelectionWho this might be right forMelanomaRenal Cell CarcinomaSarcoma+5 more Yale University 39
Large-scale testing (Phase 3)Study completedNCT02627963What this trial is testingCompare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC)Who this might be right forCarcinoma, Renal Cell AVEO Pharmaceuticals, Inc. 350
Large-scale testing (Phase 3)Study completedNCT00606866What this trial is testingMRI Study of BAY 43-9006 in Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma University of Chicago 57
Testing effectiveness (Phase 2)Study completedNCT02060370What this trial is testingSunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)Who this might be right forGenitourinary CancerKidney Cancer M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00003584What this trial is testingCombination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney CancerWho this might be right forKidney Cancer University of New Mexico 35
Early research (Phase 1)Study completedNCT01183663What this trial is testingLenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)Who this might be right forAdvanced Cancers M.D. Anderson Cancer Center 180
Not applicableLooking for participantsNCT05548621What this trial is testingA Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)Who this might be right forRenal Cell CarcinomaRenal Cell Carcinoma Metastatic St. Antonius Hospital 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07077083What this trial is testingCAIX PET/CT for Residual or Recurrent Post-ablative ccRCCWho this might be right forClear Cell Renal Cell Carcinoma (ccRCC)ccRCC Massachusetts General Hospital 10
Early research (Phase 1)Active Not RecruitingNCT05783622What this trial is testingStudy of JANX008 in Subjects With Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forNon-Small Cell Lung CancerRenal Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+4 more Janux Therapeutics 130
Testing effectiveness (Phase 2)Ended earlyNCT04260802What this trial is testingEvaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersWho this might be right forCancerNeoplasmsMetastatic Cancer+16 more Ocellaris Pharma, Inc. 73
Not applicableNo Longer AvailableNCT03874455What this trial is testingTazemetostat Expanded Access Program for Adults With Solid TumorsWho this might be right forEpithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more Epizyme, Inc.
Early research (Phase 1)Ended earlyNCT04429321What this trial is testingNivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected PrimaryWho this might be right forRenal Cell CarcinomaRenal Cell Carcinoma Stage IV Abramson Cancer Center at Penn Medicine 1